Alion awarded $1.

Of Chicago, IL on the agreement. Sigenics is your small business that designs integrated supplies and circuits examined die or packaged parts for sensor, analog and mixed-transmission applications.. Alion awarded $1.4M Army contract to develop affordable robotic prosthetic device Since 2003, 1,145 soldiers serving in Afghanistan and Iraq experienced a limb amputated. In response, Alion Technology and Science, an employee-possessed technology solutions company, is leading a simulation and modeling research work that could help improve the field of prosthetic limbs. Alion was awarded an 18-month, $1.4 million contract from the U.S. Army Medical Research Acquisition Activity to explore affordable and improved techniques in bringing robotic control technology to the field of prosthetic limbs.Fernandez, M.D., Zhuoxin Sunlight, Ph.D., Xiaopan Yao, Ph.D., Tag R. Litzow, M.D., Selina M. Luger, M.D., Elisabeth M. Paietta, Ph.D., Janis Racevskis, Ph.D., Gordon W. Dewald, Ph.D., Rhett P. Ketterling, M.D., John M. Bennett, M.D., Jacob M. Rowe, M.D., Hillard M. Lazarus, M.D., and Martin S. Tallman, M.D.: Anthracycline Dosage Intensification in Acute Myeloid Leukemia The survival of sufferers with acute myeloid leukemia is affected by many variables, including therapy that induces complete remission and appropriate consolidation therapy. Currently, cytarabine in addition anthracycline is the normal induction therapy for sufferers with AML.1 The trusted intravenous combination of daunorubicin , given daily for 3 days, and cytarabine , given daily for 7 days, outcomes in complete remission in 50 to 75 percent of individuals.1,2 Neither the addition of other medications to daunorubicin and cytarabine3 nor intensification of the dose of cytarabine4-6 has been shown to improve the results.